Feels like an 8 to 15 bagger coming up ….

over the next few weeks.

How many estimated people will see the Benzinga article?

Any chance that IDE “submission” and “approval” can be announced to us on the “same day” ???

That would be nice.

Yeah, I think he got sentenced for 7 years

Only if they assume foul play ….

We should be fine.
99% of stocks in 2020 / 2021 that ran up at least 1,000% in the OTC during that time were not halted.

DECN got halted at one point.
But their CEO was put in jail several months after.

Dr. Korenko (CEO) of RDGL is as ethical and high level integrity as they come.

We should be fine.

Do some more due diligence on this technology

Also, any FDA approval stages often cause stocks to go up at least 1,000%

George Sharp has also said this technology and company is worth “Billions” (plural), after IDE is approved. He has tweeted that multiple times before.

$5.00 is a realistic possibility ….

For within days on a run up immediately after approval.

I tend to keep it a little conservative, and then if higher, all the better

If so, we would be at $5.00 before July 31

That wouldn’t surprise me

Less than 15 days.

$1.20 after submission, $2.50+ after IDE approval

Should be near $500 million on IDE submission ….

And at or above $1 billion after IDE approval.

Thanks ….

Either way you slice it, this can be a $20 billion company someday.

And even a buyout for at least $5 billion - $10 billion before then.

That is basically 100x current share price.
And with that, that is turning each $1.00 you invest in right now - to - $100 down the road.

Thanks for posting ….

However there was also an article or tweet in which they stated that they eventually plan to seek approval to treat all types of tumors down the road. That was mentioned by them more recently, I think from sometime this year.

The GREAT news about this technology …

Apparently they have the capability for it to work on any tumor.

Malignant or Benign
Any tumor.

That is incredible upside to the value of the future market cap.

Does anyone have the link again in which it talks about how they plan to eventually get approval to treat all tumors?

$1.08 after IDE submission ….

on a run up over the course of a few days after submission. Then a slight pullback to $0.92 after.

Then a run up to $2.49 after IDE is approved, within days after approval news.

Yep ….

The MM’s won’t be able to keep this stock undervalued like this for too much longer.

Cancer cure is valued at $50 trillion ….

According to mathematical research on its value done back in 2006. With inflation since then, that means it would be worth like $100 trillion or more today.

RDGL is a very effective treatment.
The next best thing to a cure.

I imagine the “treatment” worldwide value of cancer has also got to be around $100 trillion.

If RDGL gets just 1/10 of 1% of that total market, then it would be worth $100 billion eventually for this technology.

Hence why a big pharmaceutical company may want to buy this out for say $5 billion or more, for the potential reward of $50 to $100 billion.

Know what you own here.

$50 trillion value according to this research ….

https://phys.org/news/2006-04-cancer-worth-trillion_1.html

We’ll be much higher than $0.25 after IDE submission news.

A lot higher than that.

Yeah, the current market cap should be $200+ million right now ….

Even before IDE submission, and at least $400 to $500 million after submission.

Lots of naked shorting of this stock recently ….

6 of the past 8 trading days, over 40% was shorted shares.

Could lead to a short squeeze with the right news coming ….

It’s still submitting it in Q2 though.

Yes indeed

Let’s hope so.

They keep mentioning IDE submission is still Q2 ….

Makes me think it’s going to happen in late June instead of mid June. It’s their way to keep reminding us, so we won’t worry when it’s say June 24, and it’s still not submitted just yet by then.

Just my opinion.

And not to worry.
Even if they submit it on June 27 or 28, that’s still Q2.

Regardless, we’re all good.

Yep, and remember what George Sharp tweeted ….

A week ago or so.

He tweeted and said this stock is worth billions (market cap) if and when IDE is approved.

That would be quite a few dollars per share.

Top 10 reasons to invest in RDGL ….

You can find them right here ….

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143947568

Maybe in two weeks.

George Sharp said, “few billion” dollars market cap ….

In that tweet of his from May 1.

He said “few billion dollars” market cap, if approved for human trials. We might be weeks away literally from getting approved for human trials.

Even just $4 billion / 410 million outstanding shares = $9.75 per share.

Could you imagine if George is right, and we’re sitting at $9.00+ per share later this summer?

Getting a lot of DMs looking for a comment on $RDGL.

I have always thought that the technology was breakthrough (see this blog piece https://t.co/u2hLoZg75X) and I raised a lot of money for the company (see this PR https://t.co/qUVhfA2jKs). It took a lot of years for the… https://t.co/GOAjchfMwy

— George Sharp - Advocate for truth in the OTC (@GeorgeASharp) May 1, 2024

Carnes didn’t make any money here ….

He paid money to clean up the shell and reduce the O/S from 50 million to 17 million.

And he never officially did dilute any shares once Tradition came in. And now there is no more Tradition. So no dilution (as of now up through current).

He lost money here.

The acquisition got undone.
It’s as if it never happened.
Carnes lost here (lost quite a bit of money).
As did current shareholders.
Unless a new reverse merger or acquisition play comes in here again at some point.

Time will tell.

Doubt this ever sniffs $0.06 again ….

I actually think it would bounce off of $0.10 at the lowest (in July, if they don’t submit IDE by then).

Too many would love the chance to buy another 100,000 shares for just $10,000.

With that being said, I would be stunned if they don’t submit IDE by June 30.

lol, I’m not a basher ….

When this gets IDE approval, I believe we’ll be $1.50+ minimum within days after that on a run up.

I think they’ll still submit by June 30 ….

But anything is possible in the OTC on timing.

If IDE doesn’t get submitted by June 30 ….

Then share price will go down in early July.
Probably to the $0.09 - $0.10 range.

Too many OTC holders and traders who lose their patience way today quickly.

This is my guess as well ….

Mid June submission.

Early to mid July approval.

Would be nice to get approval right before 4th of July.

Would have loved to seen him lose all his shares.

He deserves it.

Whoever sold last week made a big mistake.

Yep

Someone on the other board ….

Thinks this stock will only max out at around $0.40 per share after approval.

You can certainly tell the traders from the investors.

This is 100% true